Abstract
Malignant progression of a benign or low-grade tumor in individuals with germline alteration of SMARCB1 gene is not well characterized. In a family in which two carrier children had germline SMARCB1 mutations and atypical teratoid rhabdoid tumor, we report malignant progression of a nerve sheath tumor over a 7-year period in an affected adult family member. Prompt identification of the germline SMARCB1 alteration and the resultant rhabdoid tumor predisposition syndrome can help guide genetic counseling and surveillance in affected family members.
| Original language | English (US) |
|---|---|
| Journal | Pediatric Blood and Cancer |
| DOIs | |
| State | Accepted/In press - Jan 1 2018 |
Keywords
- Malignant progression
- NRAS mutation
- Peripheral nerve sheath tumor
- Rhabdoid tumor predisposition syndrome
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Hematology
- Oncology
Fingerprint Dive into the research topics of 'Malignant progression of a peripheral nerve sheath tumor in the setting of rhabdoid tumor predisposition syndrome'. Together they form a unique fingerprint.
Cite this
Upadhyaya, S. A., Mcgee, R. B., Wilky, B. A., & Broniscer, A. (Accepted/In press). Malignant progression of a peripheral nerve sheath tumor in the setting of rhabdoid tumor predisposition syndrome. Pediatric Blood and Cancer. https://doi.org/10.1002/pbc.27030